RecruitingNot ApplicableNCT06069583

Implementation of Support in the Care of Adults Living With Type 1 Diabetes

Using the Support Online Platform for Self-management Education of Adults Living With Type 1 Diabetes as Part of Usual Care or Independently: an Implementation Study


Sponsor

McGill University

Enrollment

322 participants

Start Date

May 5, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The investigators will conduct a trial to evaluate if an online training and support platform can help adults living with type 1 diabetes (T1D) in their diabetes self-management. Investigators will compare a group that has access to the "Support" platform through their usual medical care to a group that accesses the platform independently. The first group will be recruited through four participating clinics in the province of Quebec (Canada). The second group will be composed of adults living with T1D across Canada. Participants will have access to the platform for 12 months and will be asked to complete online questionnaires at the beginning and after 6 and 12 months, and share their glucose reader data with the research team. A subgroup of participants as well as healthcare professionals from the four clinics will be invited to participate in an individual interview aiming to understand the barriers and facilitators of integration "Support" in clinical care.


Eligibility

Min Age: 18 Years

Inclusion Criteria5

  • Diagnosis of T1D (including LADA - latent autoimmune diabetes in adults)
  • Have access to Internet
  • Use of an active email address
  • Comprehension of English or French
  • Live in Canada

Exclusion Criteria1

  • \- Unable to use the Support platform

Interventions

BEHAVIORALSupport platform

The study will be conducted over a 12-month period. This should allow participants to see their medical team 2 to 3 times during this timeframe. Participants of arms 1 and 2 will have access to the Support platform and will receive a monthly newsletter, informing them of news on the platform and acting as a reminder to log in. Several features are included in this responsive-designed platform to enhance participation, such as a visual of personal progress, ability to bookmark content, change their avatar. Support contains 3 main components: Educational material, News blog written by HCPs weekly in collaboration with patient-partners on up-to-date topics related to T1D, a peer-to-peer discussion forum which is moderated daily by a HCP specializing in T1D.


Locations(4)

Institut de recherches cliniques de Montréal

Montreal, Quebec, Canada

Centre hospitalier de l'université de Montreal

Montreal, Quebec, Canada

Centre hospitalier de Quebec, Université Laval

Québec, Quebec, Canada

Centre de médecine métabolique de Lanaudière

Terrebonne, Quebec, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06069583


Related Trials